207_Combined course Presentations

 The preferred treatment of unresectable LA-NSCLC is definitive concurrent chemotherapy and radiotherapy [I, A].

 Definitive thoracic radiotherapy should be no less than the biological equivalent of 60 Gy in 2.0 Gy fractions [I, A].

 In patients who are unfit to receive concurrent chemotherapy and radiotherapy, the sequential approach should be offered as an alternative treatment with curative intent [I, A].

Vansteenkiste J, et al. Ann Oncol. 2013;24